Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue

The following tables disaggregate our revenue from contracts with customers by business unit and geographic region (in millions). Generally, we allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.

	Three Months Ended March 31,
	2024						2023
Businesses	U.S.		Int'l		Total		U.S.		Int'l		Total
Endoscopy	$	395	$	247	$	642	$	351	$	226	$	577
Urology	356		157		513		326		143		469
Neuromodulation	190		66		256		172		62		234
MedSurg	941		470		1,412		850		430		1,280
Interventional Cardiology Therapies	195		457		652		183		408		591
Watchman	311		33		344		265		25		291
Cardiac Rhythm Management	354		221		575		345		203		548
Electrophysiology	158		143		300		85		91		177
Cardiology	1,017		854		1,872		879		727		1,606
Peripheral Interventions	299		274		573		275		229		503
Cardiovascular	1,316		1,129		2,445		1,154		956		2,110
Total Net Sales	$	2,258	$	1,599	$	3,856	$	2,003	$	1,386	$	3,389

Refer to Note K - Segment Reporting for information on our reportable segments.

	Three Months Ended March 31,
Geographic Regions	2024		2023
U.S.	$	2,258	$	2,003
Europe, Middle East and Africa	803		712
Asia-Pacific	647		548
Latin America and Canada	149		126
Total Net Sales	$	3,856	$	3,389
Emerging Markets(1)	$	648	$	529